# VRC 705: A Zika Virus DNA Vaccine in Healthy Adults and Adolescents

> **NCT03110770** · PHASE2 · COMPLETED · sponsor: **National Institute of Allergy and Infectious Diseases (NIAID)** · enrollment: 2428 (actual)

## Conditions studied

- Zika Virus
- Zika Virus Infection
- Virus Diseases
- Flavivirus Infections
- Flaviviral Diseases
- Flaviviridae Infections
- RNA Virus Infections

## Interventions

- **BIOLOGICAL:** VRC-ZKADNA090-00-VP
- **OTHER:** VRC-PBSPLA043-00-VP

## Key facts

- **NCT ID:** NCT03110770
- **Lead sponsor:** National Institute of Allergy and Infectious Diseases (NIAID)
- **Sponsor class:** NIH
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2017-03-29
- **Primary completion:** 2019-10-04
- **Final completion:** 2019-10-04
- **Target enrollment:** 2428 (ACTUAL)
- **Last updated:** 2024-01-31


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03110770

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03110770, "VRC 705: A Zika Virus DNA Vaccine in Healthy Adults and Adolescents". Retrieved via AI Analytics 2026-05-31 from https://api.ai-analytics.org/clinical/NCT03110770. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*